2024
Immunogenicity of ferroptosis in cancer: a matter of context?
Catanzaro E, Demuynck R, Naessens F, Galluzzi L, Krysko D. Immunogenicity of ferroptosis in cancer: a matter of context? Trends In Cancer 2024, 10: 407-416. PMID: 38368244, DOI: 10.1016/j.trecan.2024.01.013.Peer-Reviewed Original ResearchTumor-targeting immune responsesImmune responseCancer cellsKill malignant cellsAdaptive immune responsesInduction of ferroptosisImmunogenicity of ferroptosisAnticancer immunityMicroenvironmental defectMalignant cellsImmune cellsPlasma membrane breakdownFerroptosis inducersNecrotic formCell deathFerroptosisImbalance of cellular redox homeostasisLipid peroxidationCellsMembrane breakdownCellular redox homeostasisRedox homeostasisContext-dependent effectsImmunogenicityAdjuvanticity
2022
Proteomic characterization of post-mortem human brain tissue following ultracentrifugation-based subcellular fractionation
Kandigian SE, Ethier EC, Kitchen RR, Lam TT, Arnold SE, Carlyle BC. Proteomic characterization of post-mortem human brain tissue following ultracentrifugation-based subcellular fractionation. Brain Communications 2022, 4: fcac103. PMID: 35611312, PMCID: PMC9123841, DOI: 10.1093/braincomms/fcac103.Peer-Reviewed Original ResearchProteomic characterizationSubcellular fractionationTissue cell type compositionMultiple cellular organellesPost-mortem human brain tissueMajority of proteinsThousands of proteinsCell type compositionHuman brain tissueSame biological sampleSpatial proteomicsProtein functionProtein localizationOrganellar markersCellular organellesCellular localizationDrug targetsSubcellular levelOrganellesAbundant organellesCentrifugation fractionsProteinCell linesDisease mechanismsMembrane breakdown
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply